TLR4 and ovarian cancer: In a study in ovarian cancer cells, Kelly et al showed that the activation of TLR4 signalling promotes tumour growth and induces chemo‐resistance through recruiting the PI3K signalling axis, which in turn increases the expression of X‐linked inhibitor of apoptosis (XIAP) in the malignant cells.47